Patents by Inventor Bea Wisman

Bea Wisman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methylation of the EPB41L3 gene or the promoter of the EPB41L3 gene in a test sample comprising cervical cells
    Patent number: 10041128
    Abstract: The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: August 7, 2018
    Assignee: MD×Health SA
    Inventors: Wim Van Criekinge, Valerie Deregowski, Luc Dehaspe, G. Bea A. Wisman, Ate G. J. Van der Zee, E. M. D. Schuuring
  • Methylation of the EPB41L3 Gene or the Promoter of the EPB41L3 Gene in a Test Sample Comprising Cervical Cells
    Publication number: 20160333423
    Abstract: The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
    Type: Application
    Filed: May 24, 2016
    Publication date: November 17, 2016
    Applicant: MDxHealth S.A.
    Inventors: Wim Van Criekinge, Valerie Deregowski, Luc Dehaspe, G. Bea A. Wisman, Ate G.J. Van der Zee, E. M.D. Schuuring
  • Detection and prognosis of cervical cancer
    Patent number: 9371569
    Abstract: The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
    Type: Grant
    Filed: February 13, 2014
    Date of Patent: June 21, 2016
    Assignee: MDxHealth S.A.
    Inventors: Wim Van Criekinge, Valerie Deregowski, Luc Dehaspe, G. Bea A. Wisman, Ate G. J. Van der Zee, E. M. D. Schuuring
  • Detection and Prognosis of Cervical Cancer
    Publication number: 20150017634
    Abstract: The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
    Type: Application
    Filed: February 13, 2014
    Publication date: January 15, 2015
    Applicant: Oncomethylome Sciences S.A.
    Inventors: Wim Van Criekinge, Valerie Deregowski, Luc Dehaspe, G. Bea A. Wisman, Ate G.J. Van der Zee, E. M.D. Schuuring
  • DETECTION AND PROGNOSIS OF CERVICAL CANCER
    Publication number: 20110189653
    Abstract: The present invention relates to methods and kits for identifying, diagnosing, prognosing, and monitoring cervical cancer. These methods include determining the methylation status or the expression levels of particular genes, or a combination thereof.
    Type: Application
    Filed: March 23, 2009
    Publication date: August 4, 2011
    Inventors: Wim Van Criekinge, Valerie Deregowski, Luc Dehaspe, G.Bea A. Wisman, Ate G.J. Van Der Zee, E. M.D. Schuuring
  • Methylation Markers for Diagnoses and Treatment of Cancers
    Publication number: 20090203639
    Abstract: Two hundred ten markers are provided which are epigenetically silenced in one or more cancer types. The markers can be used diagnostically, prognostically, therapeutically, and for selecting treatments that are well tailored for an individual patient. Restoration of expression of silenced genes can be useful therapeutically, for example, if the silenced gene is a tumor-suppressor gene. Restoration can be accomplished by supplying non-methylated copies of the silenced genes or polynucleotides encoding their encoded products. Alternatively, restoration can be accomplished using chemical demethylating agents or methylation inhibitors. Kits for testing for epigenetic silencing can be used in the context of diagnostics, prognostics, or for selecting “personalized medicine” treatments.
    Type: Application
    Filed: April 17, 2006
    Publication date: August 13, 2009
    Applicant: Oncomethylome Sciences, Inc.
    Inventors: Wim Van Criekinge, Josef Straub, Bea Wisman
  • ESR1 and Cervical Cancer
    Publication number: 20090023137
    Abstract: The present invention provides methods and kits for detecting susceptibility to, or the incidence of, cervical cancer in a sample comprising determining the methylation status of the ESR1 gene, optionally as part of a panel of genes. Also provided are methods and kits which involve determining the expression levels of genes including the ESR1 gene in order to diagnose cervical cancer.
    Type: Application
    Filed: July 7, 2005
    Publication date: January 22, 2009
    Inventors: Ate Van Der Zee, Bea Wisman